Improvement of Cutaneous Hereditary Hemorrhagic Telangiectasia With Pazopanib—A Multikinase Inhibitor

Improvement of Cutaneous Hereditary Hemorrhagic Telangiectasia With Pazopanib—A Multikinase Inhibitor

This case report describes a patient with hereditary hemorrhagic telangiectasia that was complicated by cutaneous telangiectasias, gastrointestinal arteriovenous malformations with bleeding, nosebleeds, and liver and pulmonary arteriovenous malformations.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of dermatology (1960) 2022-02, Vol.158 (2), p.214-216
Hauptverfasser: Moon, June Young, Ajebo, Etsubdenk M, Gossage, James R, Belcher, Matthew D
Format: Artikel
Sprache:eng
Schlagworte:
Dermatology
Genetic disorders
Hemorrhage
Humans
Indazoles
Inhibitor drugs
Pyrimidines - therapeutic use
Skin diseases
Sulfonamides - therapeutic use
Telangiectasia, Hereditary Hemorrhagic - diagnosis
Telangiectasia, Hereditary Hemorrhagic - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This case report describes a patient with hereditary hemorrhagic telangiectasia that was complicated by cutaneous telangiectasias, gastrointestinal arteriovenous malformations with bleeding, nosebleeds, and liver and pulmonary arteriovenous malformations.
ISSN:2168-6068
2168-6084
DOI:10.1001/jamadermatol.2021.5132